
Nymox Pharmaceutical Corporation NYMX
Annual report 2024
added 12-13-2025
Nymox Pharmaceutical Corporation DIO Ratio 2011-2025 | NYMX
Annual DIO Ratio Nymox Pharmaceutical Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 5.46 | 85.7 | 186 | 29.8 | 61.1 | 29.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 186 | 5.46 | 66.2 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amphastar Pharmaceuticals
AMPH
|
132 | $ 25.27 | -2.43 % | $ 1.22 B | ||
|
Aclaris Therapeutics
ACRS
|
42.1 | $ 3.26 | -3.12 % | $ 252 M | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Kamada Ltd.
KMDA
|
166 | $ 7.03 | 0.14 % | $ 260 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
AstraZeneca PLC
AZN
|
206 | $ 89.78 | -0.57 % | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Anika Therapeutics
ANIK
|
247 | $ 9.57 | 0.84 % | $ 140 M | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
209 | $ 2.34 | 2.59 % | $ 14.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 1.29 | -3.01 % | $ 7.03 M | ||
|
Baudax Bio
BXRX
|
596 | - | 0.59 % | $ 63 K | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 14.01 | -8.49 % | $ 922 M | ||
|
ChromaDex Corporation
CDXC
|
114 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
116 | $ 566.18 | -2.56 % | $ 42.9 B | ||
|
Cerus Corporation
CERS
|
213 | $ 2.16 | 0.47 % | $ 399 M | ||
|
Caladrius Biosciences
CLBS
|
35.8 | - | -16.75 % | $ 25.8 M | ||
|
Clovis Oncology
CLVS
|
271 | - | -7.23 % | $ 13 M | ||
|
Biogen
BIIB
|
394 | $ 174.42 | 1.11 % | $ 25.4 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.04 K | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
239 | $ 11.54 | 0.87 % | $ 746 M |